We have compared the properties of the [3H]Ins(1,4,5)PJ-binding sites from a number of tissues in an attempt to determine if heterogeneity exists within the Ins(1,4,5)P3-receptor family. The binding of Ins(1,4,5)P3 was characterized in detail by using membranes prepared from human uterine smooth muscle and bovine adrenal cortex. Ins(1,4,5)P3 exhibited an approx. 5 times greater affinity for the binding site in adrenal cortex (KD = 9.81 + 1.92 nM) compared with uterine smooth muscle (KD = 37.1+1.8 nM). The binding was dependent on pH in both tissues, with a maximum at pH 8.3; at this pH various inositol phosphates and nucleotides competed for the binding sites with similar potencies on both tissues. However, the binding of Ins(1,4,5)P3 to the uterine smooth-muscle membranes was Ca2+-sensitive, whereas that to the bovine adrenal cortex was not; furthermore, heparin displaced the binding of Ins(1,4,5)PJ in the uterus with an IC50 value (concn. of displacer giving 50 % inhibition of specific binding) of 3.9 ,g/ml (2.5, 6.4; lower, upper range), compared with a value of 22 (13, 30) ,ig/ml in adrenal cortex. In view of the ability of Ins(1,4,5)P3 and heparin to distinguish between these binding sites, their effect on other tissues was examined. Ins(1,4,5)P3 showed a similar affinity for receptors located in the bovine cerebellum to those in the bovine adrenal cortex, but heparin displaced Ins(1,4,5)P3 binding with a 5-fold greater affinity from the cerebellum. Ins(1,4,5)P3 had a 2-fold greater affinity for its receptor with human platelets, as compared with human uterus, but heparin was unable to distinguish between these sites. In guinea-pig ileum, Ins(1,4,5)P3 displayed a similar affinity for the receptors in the longitudinal muscle compared with the circular muscle, but heparin could distinguish between these sites. These data show that small differences exist between tissues, but no clear picture is apparent. It is possible that these results reflect tissue-dependent factors such as phosphorylation, the presence of calmedin etc., rather than the presence of receptor subtypes or species difference.
INTRODUCTION
Inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] is now established as a second messenger mediating the release of intracellular Ca2l from non-mitochondrial stores (Streb et al., 1983; Prentki et al., 1984) . The existence of an Ins(l,4,5)P3 receptor was first suggested from radioligand-binding experiments (Baukal et al., 1985; Spat et al., 1986; Guillemette et al., 1987; Worley et al., 1987) . This was confirmed when an Ins(1,4,5)P3-binding site was purified to homogeneity from rat cerebellum (Supattapone et al., 1988a) , and later from mouse cerebellum, where it has been cloned, sequenced and expressed in the NG108-15 cell line (Furuichi et al., 1989) . In addition, reconstitution ofthis purified protein into planar lipid membranes has revealed that the Ins(1,4,5)P3 receptor is a Ca2l channel (Ferris et al., 1989) .
Although binding sites for Ins(1,4,5)P3 have been described in many different tissues, variations exist in the reported affinity (KD) values. For example, in rat cerebellum the KD value for Ins(1,4,5)P3 is approx. 40 nm (Worley et al., 1987) , compared with 5 nm in bovine adrenal cortex (Baukal et al., 1985; Palmer et al., 1988a) . In addition, the mucopolysaccharide heparin has been shown to have different IC50 values (the concentration of displacer required to inhibit 50 % of specific binding) for these two tissues, and these results have led to the suggestion of Ins(1,4,5)P3 receptor subtypes (Willcocks & Nahorski, 1989) .
Since the binding of Ins(1,4,5)P3 to its receptor is sensitive to pH, the presence of bivalent cations and nucleotides, and possibly temperature, it is unclear whether these differences are real or represent differences in tissue preparation and experimental conditions. In the present study, therefore, we have characterized the binding of [3HIns(1, 4, 5) P3 to membranes from bovine ad-renal cortex and human uterus prepared under identical conditions, and show that Ins(1,4,5)P3 has different KD values for these two sites. In addition, these sites can be further distinguished by using heparin. The affinity of Ins(1,4,5)P3 and the ability of heparin to displace Ins(1,4,5)P3 binding were examined on other tissues such as bovine cerebellum, human platelets, guinea-pig ileum, rat cerebral cortex and rat cerebellum in an attempt to previous 24 h. Bovine adrenal cortex and bovine cerebellum were obtained fresh from the abattoir. Rat cerebellum was dissected from male Wistar rats (100-300 g). Guinea-pig ileum was taken from animals of the Dunkin-Hartley strain (350-360 g), and the longitudinal and circular muscle was dissected from it as described by Bitar & Makhlouf (1982) .
Homogenates of the tissues (except platelets) were prepared essentially as described by Worley et al. (1987) . Briefly, tissues were homogenized (Polytron, setting 9) in 10 vol. of ice-cold buffer A (20 mM-NaCl, 100 mM-KCl, 50 mM-Tris/HCl, 1 mm-EDTA, pH 8.3) and centrifuged at 1000 g for 15 min at 4 'C. The supernatants were pooled and centrifuged at 35000 g for 15 min at 4 'C, and the resulting pellets washed with a further 10 vol. of buffer and recentrifuged. The pellets were resuspended in buffer at a protein concentration of approx. 10 mg/ml and stored at -20 'C in 5 ml batches; activity was retained for at least 3 months. Platelets were suspended in buffer B (10 mM-Hepes, pH 7.4, containing 2 mM-EDTA) and disrupted by sonication (4 x 30 s) and centrifuged at 800 g for 10 min. Hill (1910) , and saturation curves were fitted to a rectangular hyperbola. Both equations were fitted by using the computer program 'GraphPAD' (ISI Software).
RESULTS
Characterization of Ins(1,4,5)P3 binding in bovine adrenal cortex and human uterus Consistent with the results in other tissues, the binding of Ins(1,4,5)P3 to membranes prepared from bovine adrenal cortex and uterine smooth muscle was extremely rapid and reached equilibrium within 2 min (Fig. 1) . Similarly, the dissociation of Ins(1,4,5)P3 was very rapid, with a half-life of approx. 10 s ( The binding of Ins(1,4,5)P3 was markedly altered by pH in both tissues, with specific binding increasing with pH up to a maximum at pH 8.3 (Fig. 2) . Saturation analysis experiments performed at pH 8.3 revealed Hill coefficients (h) of 0.97+0.10 for human uterus, and 0.95+0.08 for bovine adrenal cortex. Scatchard transformations gave apparent KD values of 37.1 + 1.8 nM (n = 36) and 9.81 + 1.92 nm (n = 8) in uterine smooth muscle and adrenal cortex respectively (Fig. 3) . For both tissues, binding was to a single site with a density (Bmax) of 1.47 +0.4 pmol/mg ofprotein and 2.91 + 0.51 pmol/mg ofprotein for the human uterus and bovine adrenal cortex respectively. The density of sites for the bovine adrenal cortex is higher than reported by others (Baukal et al., 1985; Guillemette et al., 1989; Challiss et al., 1990) Ins(1,4,5)PJ-binding site was investigated. As shown in Table 1 , all of the isomers studied were considerably less potent than Ins(1,4,5)PJ, and demonstrated similar profiles on both tissues.
For example, Ins(1,3,4,5)P4, which has been suggested to be a second messenger controlling the re-filling of the Ins(1,4,5)P3-sensitive Ca2+ pool (Irvine et al., 1988) , was 15-fold and 20-fold less potent than Ins(1,4,5)P3 in uterine smooth muscle and bovine adrenal cortex respectively. Several nucleoside triphosphates were also investigated for their ability to displace the binding of Ins(1,4,5)P,. GTP was the most potent displacer, with an IC50 of approx. 150 /SM in both tissues, whereas ATP was 2-3 times less potent (Table 1) . Other nucleotides, namely CTP, TTP, UTP, ITP and XTP, displaced the binding with IC50 values in the range 500-2000,UM; values were almost identical in both tissues. The Ins(1,4,5)P3-binding sites in both tissues could be distinguished by using heparin. Heparin displaced the binding of Ins(1,4,5)P, Ins(1,4,5)P3 in adrenal cortex with an IC50 of 22 ,ug/ml (13, 30 ,ug/ml; lower, upper range), compared with a value of 4.1 ,ug/ml (2.5, 6.4) in uterine smooth muscle (Fig. 4) . The Hill coefficients obtained from the inhibition curves were not significantly different from unity (Table 2) . If these results are expressed relative to Ins(1,4,5)P3, heparin has an approx. 30 times greater potency for the Ins(1,4,5)P3-binding site in uterine smooth muscle than in adrenal cortex. Scatchard plots determined in the presence of a fixed concentration of heparin (10/ug/ml) suggest that, in the tissues studied (bovine adrenal cortex, human uterus and rat cerebellum), heparin acts as a competitive inhibitor at the same site as Ins(1,4,5)P3 (Fig. 5) .
Ca2+ produced an inhibition of the binding of Ins(1,4,5)P3 in uterine smooth muscle at the intracellular pH of 7.1, with an IC50 of approx. 100 nM (Fig. 6 ), but had no affect on Ins(1,4,5)P3 binding in adrenal cortex. Mg2+ was found to inhibit the binding of Ins(1,4,5)P3 in both tissues at pH 7.1, with an IC50 value of 100 fiM. Since these ions are known to stimulate metabolism of Ins(1,4,5)P3 (Storey et al., 1984; Biden & Wollheim, 1986) Ins(1,4,5)P3 bound to membranes prepared from human platelets with a A value of 21+2 nm, compared with 37+ 1.8 nm for the human uterus, but the IC50 of heparin was almost identical on both of these tissues, with a value of approx. 4 ,ug/ml (Table   2 ). However, with bovine tissue, Ins(1,4,5)P3 showed a similar affinity for receptors located in the bovine cerebellum to those in the bovine adrenal cortex (9.81 + 1.92 and 11.0 + 0.51 nm respectively), but heparin displaced Ins(1,4,5)P3 binding with a 5-fold greater potency on the cerebellum [IC50 = 3.8 (2.4, 6) ,ug/ml] compared with the adrenal cortex [IC50 = 19.8 (13, 30) utg/ml].
In the guinea-pig ileum, the affinity of Ins(1,4,5)P3 for its receptor in the longitudinal" muscle was similar to that obtained in the circular muscle (4.2 + 0.9 nm and 6.9 + 1.2 nm respectively). Heparin, however, distinguished between these tissues, since it was approx. 10-fold more active in displacing Ins(1,4,5)P3 from the longitudinal muscle compared with the circular muscle, with IC50 values of 4.3 (2.4, 7.5) ,ug/ml and 52 (32, 85) ,ug/ml respectively. KD values for Ins(1,4,5)P3 were different for the rat cerebellum and the rat cerebral cortex; Ins(1,4,5)P3 showed a greater affinity for receptors located in the cerebral cortex than for those of the cerebellum (23 + 3 nM and 37 + 5 nm respectively), but heparin did not distinguish between these two tissue preparations [6.54 (3.9 , 1 1.1),ug/ml for cerebellum, and 6.18 (4.1, 9.6) 4ug/ml
for cortex]. In all of these tissue preparations. the binding of Ins(1,4,5)P3 was to a single site, and Hill coefficients of heparin displacement curves were not significantly different from unity (Table 2) .
DISCUSSION
Differences in Ins(1,4,5)P3-binding sites
The ability 'of inositol phosphates to compete for the Ins-
(1,4,5)P3-binding site in bovine adrenal cortex and human uterus parallels closely their ability to stimulate the release of Ca2 , suggesting that the binding is to the Ins(1,4,5)P3 receptor rather than Ins(1,4,5)P3 3-kinase or 5-phosphatase (Nahorski, 1988) . In addition, heparin, which inhibits Ins(1,4,5)P3-induced Ca2+ release in a number of tissues, displaces Ins(1,4,5)P. binding with an affinity of the same order as that for inhibition of Ca2+ release in bovine adrenal cortex (Guillemette et al., 1989) .
However, small differences in the affinity of Ins(1,4,5)P3 and heparin for Ins(l,4,5)PJ-binding sites have been reported in the literature (see the Introduction), and these may reflect the existence of receptor subtypes (Willcocks & Nahorski, 1989) . It is unclear, however, whether these differences are real or represent differences in tissue preparation and experimental conditions, since the binding of Ins(1,4,5)P3 is sensitive to pH, bivalent cations and nucleotides. Care has therefore been taken to ensure that in the present study tissue preparation and binding experiments have been carried out under identical conditions to allow a direct comparison of the results. The characteristics of the binding site in human uterus are almost identical with those described for the Ins(1,4,5)P3 receptor in rat cerebellum (Willcocks & Nahorski, 1989) , and can be distinguished from the binding site in the bovine adrenal cortex by the affinity of heparin and Ins(1,4,5)P3.
The results of Willcocks & Nahorski (1989) (Willcocks & Nahorski, 1989) , is probably an inter-species difference. It is possible that the small differences in the affinity of Ins(1,4,5)P3
within a species may be attributed to factors such as variable phosphorylation of Ins(1,4,5)P3 receptors. Indeed, it has been reported that the Ins(1,4,5)P3 receptor in rat and mouse cerebellum can be phosphorylated by a cyclic-AMP-dependent protein kinase (Supattapone et al., 1988b; Furuichi et al., 1989) .
Heparin acts as an antagonist at the Ins(1,4,5)P3 receptor (Worley et al., 1987) , and also inhibits the Ins(1,4,5)P3 3-kinase and the Ins(1,4,5)P3 5-phosphatase, but with different affinities (Guillemette et al., 1989 (1,4,5)P3, and is not species specific. However, it should be noted that heparin is a considerably larger molecule than Ins(1,4,5)P3, and thus differences in the affinity of heparin between tissues may simply be due to the access difficulties associated with the larger molecule. The different KD values of Ins(1,4,5)P3 and IC50 values of heparin between different tissues cannot be attributed to variable metabolism.
We therefore consider there to be Ins(1,4,5)P3 receptors present in the same species, and between species, with different affinities for Ins(1,4,5)P3 and heparin. However, although these affinities vary slightly between tissues, there is no consistent pattern to suggest distinct subtypes of the Ins(l,4,5)P3 receptor.
The small changes in affinity may therefore be due to different forms of post-translational modifications such as phosphorylation or differences in the lipid environment, e.g. it has been shown that the affinity of ligands for muscarinic receptors is modulated by the lipid environment (Berstein et al., 1989) .
It has recently been reported that Ins(1,4,5)P3 receptors in the rat liver can exist in two states which display different affinities for Ins(1,4,5)P3, and that the balance between these two states can be altered by Ins(1,4,5)P3-dependent hormones (Mauger etal., 1989) . However, in all our preparations only a single affinity for the Ins(1,4,5)P3-binding site could be detected (but see Challiss et al., 1990) . The possibility of one state of these receptors being lost under our experimental conditions requires investigation.
Physiological relevance of displacement of Ins(1,4,5)P3 binding by pH, ATP, Ca2l and Mg2"
The observation that intracellular concentrations of Ca2l ions inhibit the binding of Ins(1,4,5)P3 in the uterus is in agreement with results from rat cerebellum (Worley et al., 1987) . Those authors ascribed the inhibitory action of Ca2+ to an allosteric effect mediated by the Ca2+-binding protein calmedin, loosely associated with the receptor. It is unclear as to why the binding in the bovine adrenals (and other peripheral tissues that we have studied) is unaffected by Ca2+; whether this is due to the absence of calmedin from these tissues, or because the Ins(1,4,5)P3 receptors in these tissues are insensitive to calmedin, remains to be seen.
Ins(1,4,5)P3 binding was dependent on pH, and it has been suggested that this may be of physiological relevance, since intracellular pH is increased by growth factors and hormones (Worley et al., 1987) . Further, nucleotides such as ATP and GTP also compete for Ins(1,4,5)P3-binding sites at concentrations close to their intracellular levels, suggesting that they may also regulate the binding ofIns(l,4,5)P3. However, it is not known whether the nucleotides retain their ability to bind to the Ins(1,4,5)P3 receptor when complexed with Mg2+ ions, the predominant species found within cells. Interestingly, Mg2+ ions also displaced the binding of Ins(1,4,5)PJ, possibly as a consequence of binding directly toIns(l,4,5)P3, at a concentration at least one order of magnitude less than that found within cells (intracellular free concentration 1 mM; Rink et al., 1982) .
The level of Ins(1,4,5)P3 found within unstimulated cells is low-micromolar (Challis et al., 1988; Chilvers et al., 1989; Palmer et al., 1988b) 
